Drew Moghanaki: Long-term stability in QoL showing patients with lung cancer treated with CRT
Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at UCLA, shared an article by Marloes Nies, et al. on X:
“A prospective longitudinal study of 574 patients with lung cancer treated with CRT between 2013 and 2020 at University Medical Center Groningen in the Netherlands reports long-term stability in QoL.”
Recovery of quality of life in 574 patients with inoperable lung cancer undergoing (chemo)radiotherapy.
Authors: Marloes Nies, et al.
Summary of the article:
This study assessed long-term quality of life (QoL) in 574 patients with inoperable lung cancer undergoing (chemo)radiotherapy. QoL declined immediately post-treatment but gradually returned to near-baseline levels within 3–24 months and remained stable up to five years.
Patients with pulmonary comorbidities and poor performance status experienced more complaints. These findings highlight the temporary impact of treatment on QoL and the need for supportive care in high-risk patients.
More posts featuring Drew Moghanaki.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023